Cargando…

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

BACKGROUND: Efficacy studies indicate anti-depressive effects of at least some second generation antipsychotics (SGAs). The Bergen Psychosis Project (BPP) is a 24-month, pragmatic, industry-independent, randomized, head-to-head comparison of olanzapine, quetiapine, risperidone and ziprasidone in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjelby, Eirik, Jørgensen, Hugo A, Kroken, Rune A, Løberg, Else-Marie, Johnsen, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178484/ https://www.ncbi.nlm.nih.gov/pubmed/21884578 http://dx.doi.org/10.1186/1471-244X-11-145

Ejemplares similares

Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study
por: Johnsen, Erik, et al.
Publicado: (2013)

Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
por: Johnsen, Erik, et al.
Publicado: (2010)

Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: A Cross-Sectional Study
por: Johnsen, Erik, et al.
Publicado: (2011)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

Influence of different second generation antipsychotics on the QTc interval: A pragmatic study
por: Olsen, Roy E, et al.
Publicado: (2016)

Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial
por: Sinkeviciute, Igne, et al.
Publicado: (2021)

Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel, A
Publicado: (2013)

T16. SCHIZOPHRENIA SPECTRUM DISORDER: DEPRESSION TRAJECTORIES AND IMMUNE MARKERS
por: Hoprekstad, Gunnhild, et al.
Publicado: (2020)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone
por: Gómez-Revuelta, Marcos, et al.
Publicado: (2020)

A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009)

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT
por: Anda, Liss, et al.
Publicado: (2021)

Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
por: Chaudhry, Haroon Rashid, et al.
Publicado: (2008)

The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement
por: Anda, Liss, et al.
Publicado: (2016)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
por: Johnsen, Erik, et al.
Publicado: (2013)

Evaluation of intramuscular olanzapine and ziprasidone in the medically ill
por: Patel, Seema M., et al.
Publicado: (2021)

Comparison of Mental Health Resources Used by Patients With Bipolar Disorder Treated With Risperidone, Olanzapine, or Quetiapine
por: Gianfrancesco, Frank, et al.
Publicado: (2005)

M47. AKATHISIA AND ATYPICAL ANTIPSYCHOTICS: EXPLORING ASSOCIATIONS TO SUICIDALITY AND AGITATION
por: Bjarke, Jill, et al.
Publicado: (2020)

S87. THE INITIAL CHANGE IN THE SERUM LEVEL OF C-REACTIVE PROTEIN IN ACUTE PSYCHOSIS IS ASSOCIATED WITH COGNITIVE PERFORMANCE IN LATER PHASES
por: Fathian, Farivar, et al.
Publicado: (2018)

Corrigendum: An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2013)

An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
por: Løberg, Else-Marie, et al.
Publicado: (2012)

The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
por: Johnsen, Erik, et al.
Publicado: (2016)

Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
por: Fathian, Farivar, et al.
Publicado: (2018)

Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole
por: Remmerie, Bart, et al.
Publicado: (2016)

Patients with Schizophrenia Fail to Up-Regulate Task-Positive and Down-Regulate Task-Negative Brain Networks: An fMRI Study Using an ICA Analysis Approach
por: Nygård, Merethe, et al.
Publicado: (2012)

Corrigendum: Patients with schizophrenia fail to up-regulate task-positive and down-regulate task-negative brain networks: an fMRI study using an ICA analysis approach
por: Nygård, Merethe, et al.
Publicado: (2013)

The Repurposing of Anti-Psychotic Drugs, Quetiapine and Olanzapine, as Anti-Cryptococcus Drugs
por: Ogundeji, Adepemi O., et al.
Publicado: (2017)

The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability
por: Løberg, Else-Marie, et al.
Publicado: (2014)

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
por: Zhang, Hongyan, et al.
Publicado: (2011)

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
por: Stabell, L.A, et al.
Publicado: (2023)

Elderly patients with no previous psychiatric history: suicidality and other factors relating to psychiatric acute admissions
por: Lund-Heimark, Hallvard, et al.
Publicado: (2020)

Switching to quetiapine for risperidone-induced amenorrhea: Report of two cases
por: Pardal, P. K., et al.
Publicado: (2010)

Immune-globulin/quetiapine/risperidone: Lack of efficacy: case report
Publicado: (2022)

F184. TESTING THE GABA-GLUTAMATE HYPOTHESIS FOR SCHIZOPHRENIA IN RELATION TO AUDITORY HALLUCINATIONS - PRELIMINARY RESULTS
por: Hjelmervik, Helene, et al.
Publicado: (2018)

Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study
por: Park, Subin, et al.
Publicado: (2013)

Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
por: Kishi, Taro, et al.
Publicado: (2019)

A Critical Review of Pro-Cognitive Drug Targets in Psychosis: Convergence on Myelination and Inflammation
por: Kroken, Rune A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0lpk6n1lqj3tl5veuamipgd5cu